It activates NF-κB and MAPK signaling pathways to suppress apoptosis, promote proliferation and survival, and induce EMT—mediated by transcription factors including Snail and ZEB1—thereby enhancing the migratory, invasive, and metastatic capacity of prostate cancer cells. This evidence concerns the gene NFKB1 and Familial prostate cancer.